AI Screening System For Blindness Associated With Diabetes Gets FDA Nod

The US FDA has cleared an AI-based diagnostic from Israeli firm AEYE Health that screens for diabetic retinopathy, a leading cause of blindness.

Diabetic Eye
• Source: Shutterstock

AEYE Health has developed an automated diagnostic tool that could prevent millions of diabetics from losing their sight.

The Tel Aviv based digital health company recently announced it received 510(k) clearance from the US Food and Drug Administration...

More from Regulation

More from Policy & Regulation